Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May;30(4):179-85.
doi: 10.1177/0885066613503278. Epub 2013 Sep 24.

Amiodarone-induced thyroid dysfunction

Affiliations
Review

Amiodarone-induced thyroid dysfunction

Sara Danzi et al. J Intensive Care Med. 2015 May.

Abstract

Amiodarone is an effective medication for the treatment of cardiac arrhythmias. Originally developed for the treatment of angina, it is now the most frequently prescribed antiarrhythmia drug despite the fact that its use is limited because of potential serious side effects including adverse effects on the thyroid gland and thyroid hormones. Although the mechanisms of action of amiodarone on the thyroid gland and thyroid hormone metabolism are poorly understood, the structural similarity of amiodarone to thyroid hormones, including the presence of iodine moieties on the inner benzene ring, may play a role in causing thyroid dysfunction. Amiodarone-induced thyroid dysfunction includes amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH). The AIT develops more commonly in iodine-deficient areas and AIH in iodine-sufficient areas. The AIT type 1 usually occurs in patients with known or previously undiagnosed thyroid dysfunction or goiter. The AIT type 2 usually occurs in normal thyroid glands and results in destruction of thyroid tissue caused by thyroiditis. This is the result of an intrinsic drug effect from the amiodarone itself. Mixed types are not uncommon. Patients with cardiac disease receiving amiodarone treatment should be monitored for signs of thyroid dysfunction, which often manifest as a reappearance of the underlying cardiac disease state. When monitoring patients, initial tests should include the full battery of thyroid function tests, thyroid-stimulating hormone, thyroxine, triiodothyronine, and antithyroid antibodies. Mixed types of AIT can be challenging both to diagnose and treat and therapy differs depending on the type of AIT. Treatment can include thionamides and/or glucocorticoids. The AIH responds favorably to thyroid hormone replacement therapy. Amiodarone is lipophilic and has a long half-life in the body. Therefore, stopping the amiodarone therapy usually has little short-term benefit.

Keywords: T3; amiodarone-induced thyrotoxicosis; heart; hyperthyroidism; hypothyroidism; thyroid hormone; thyrotoxicosis; triiodothyronine.

PubMed Disclaimer

Similar articles

  • [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G, Filus A, Kuliczkowska J, Bugajski J. Bednarek-Tupikowska G, et al. Postepy Hig Med Dosw (Online). 2004 Apr 20;58:216-25. Postepy Hig Med Dosw (Online). 2004. PMID: 15114257 Review. Polish.
  • Amiodarone and the thyroid.
    Jabrocka-Hybel A, Bednarczuk T, Bartalena L, Pach D, Ruchała M, Kamiński G, Kostecka-Matyja M, Hubalewska-Dydejczyk A. Jabrocka-Hybel A, et al. Endokrynol Pol. 2015;66(2):176-86. doi: 10.5603/EP.2015.0025. Endokrynol Pol. 2015. PMID: 25931048 Review.
  • Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F, Bartalena L, Martino E. Bogazzi F, et al. J Clin Endocrinol Metab. 2010 Jun;95(6):2529-35. doi: 10.1210/jc.2010-0180. J Clin Endocrinol Metab. 2010. PMID: 20525904 Review.
  • [Amiodarone-induced thyrotoxicosis].
    Bogazzi F, Tomisti L, Di Bello V, Martino E. Bogazzi F, et al. G Ital Cardiol (Rome). 2017 Mar;18(3):219-229. doi: 10.1714/2674.27399. G Ital Cardiol (Rome). 2017. PMID: 28398380 Review. Italian.
  • The effects of amiodarone on the thyroid.
    Martino E, Bartalena L, Bogazzi F, Braverman LE. Martino E, et al. Endocr Rev. 2001 Apr;22(2):240-54. doi: 10.1210/edrv.22.2.0427. Endocr Rev. 2001. PMID: 11294826 Review.

Cited by

LinkOut - more resources